SEARCH:      Monitor Keywords |  Custom RSS

Organic compounds -- part of the class 532-570 series January recently filed with US Patent Office 01/09

20090030195 - 1-(2h)-isoquinolone derivative: wherein X represents an aryl group or heteroaryl group which may be substituted, Cy represents a 4- to 7-membered monocyclic heterocyclic ring or a 8- to 10-membered condensed heterocyclic ring which may be substituted, and Z represents O, S, or NRa; or a prodrug thereof; or a pharmaceutically acceptable salt... Agent: Browdy And Neimark, P.l.l.c. 624 Ninth Street, Nw

20090023914 - Process for preparing drospirenone and intermediate thereof: The present invention encompasses processes for preparing drospirenone and intermediates thereof.... Agent: Kenyon & Kenyon LLP

20090023915 - Process for the preparation of faropenem: The present invention is related to processes for the preparation of faropenem.... Agent: Ranbaxy Inc.

20090023916 - Tetrazine-based bio-orthogonal coupling reagents and methods: Coupling reactions, suitable for use in organic or aqueous media, are performed by contacting a 1,2,4,5-tetrazine with a dienophile. The dienophile may be covalently bonded to a protein, and the coupling reaction may be performed in biological media such as those containing cells or cell lysates. The reactions may be... Agent: Ratnerprestia

20090023917 - Selective estrogen receptor modulators for the treatment of vasomotor symptoms: The present invention relates to a selective estrogen receptor modulator of formula I or Ia: (I) (Ia); or a pharmaceutical acid addition salt thereof; useful for treating vasomotor symptoms, in particular hot flashes, night sweats and other symptoms that affect women around menopause.... Agent: Eli Lilly & Company

20090018328 - Phthalocyanine compound and method for producing the same, and coloring composition containing the phthalocyanine compound: in the above general formula (1), M represents a divalent to tetravalent metal atom or two hydrogen atoms, and rings A1, A2, A3 and A4 each independently represents a benzene ring or a structure represented by the above general formula (2), provided that at least one of rings A1, A2,... Agent: Westerman, Hattori, Daniels & Adrian, LLP

20090018329 - Novel heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors:

20090012286 - Process for the preparation of 17-(3-hydroxypropyl)-17-hydroxysteroids: P

20090012287 - Process for producing penam compound: An object of the invention is to provide an industrially advantageous process capable of remarkably suppressing the generation of an undesirable by-product cepham compound to thereby efficiently produce a desired 2α-methyl-2β-[(1,2,3-triazol-1-yl)methyl]penam-3α-carboxylic acid ester. In the present invention, a diphenylmethyl 2β-bromomethyl-2α-methylpenam-3α-carboxylate (BMPB) is reacted with 1,2,3-triazole in a halogenated hydrocarbon solvent... Agent: Posz Law Group, PLC

20090012288 - Process for preparation of pentostatin (r)-3-(2-deoxy-beta-d-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz[4,5-d][1,3] diazepin-8-ol:

20090005555 - Titanyl phthalocyanine processes and photoconductors thereof: A process which includes treating, mixing, or contacting a Type I titanyl phthalocyanine with a weak acid with a pKa of at least equal to or greater than about 0; dissolving the acid treated Type I titanyl phthalocyanine in a solution of a trihaloacetic acid and an alkylene halide; adding... Agent: Patent Documentation Center

20090005556 - Process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2,3-b] [1,5]benzodiazepine: Disclosed is a process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine. The process comprises of reacting 2-(2-aminoanilino)-5-methylthiophene-3-carbonitrile with N-methyl piperazine in conjunction with N-methylpiperazine acid salt, to produce 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine. Also disclosed is a process for obtaining the Polymorphic Form I of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine by crystallizing the crude 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine... Agent: Darby & Darby P.C.